RECRUITING

ASCENT Intervention for Brain Tumor Patients

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this study is to refine and test a psychosocial intervention called ASCENT (ACT-based Supportive intervention for patients with CENTral nervous system tumors). This intervention was developed to help patients after being diagnosed with a brain tumor. The main question this study aims to answer is whether this intervention is feasible (i.e., possible to carry out) and acceptable (i.e., considered helpful) to patients. Participants will be asked to take part in 6 coaching sessions and complete short surveys at four different time points. Some participants will be asked to share feedback via interviews.

Official Title

An ACT-Based Supportive Intervention for Patients With Central Nervous System Tumors

Quick Facts

Study Start:2025-05-15
Study Completion:2029-07-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06099743

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age ≥ 18
  2. * Massachusetts General Hospital Cancer Center Patient
  3. * Within 6 months of diagnosis of malignant primary Central Nervous System (CNS) tumor
  4. * English speaking
  1. * Inability to provide informed consent as assessed by the study team (e.g., due to severe cognitive impairment/dementia)
  2. * Moderate to severe receptive aphasia (Quick Aphasia Battery sentence comprehension subscale \< 8)
  3. * Current or imminent hospice enrollment

Contacts and Locations

Study Contact

Deborah A Forst, MD
CONTACT
617-724-4000
dforst@mgb.org

Principal Investigator

Deborah A Forst, MD
PRINCIPAL_INVESTIGATOR
Massachusetts General Hospital

Study Locations (Sites)

Massachusetts General Hospital Cancer Center
Boston, Massachusetts, 02114
United States

Collaborators and Investigators

Sponsor: Massachusetts General Hospital

  • Deborah A Forst, MD, PRINCIPAL_INVESTIGATOR, Massachusetts General Hospital

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-05-15
Study Completion Date2029-07-31

Study Record Updates

Study Start Date2025-05-15
Study Completion Date2029-07-31

Terms related to this study

Keywords Provided by Researchers

  • glioma
  • supportive care
  • brain tumor
  • psychological distress
  • support

Additional Relevant MeSH Terms

  • Malignant Brain Tumor
  • Glioma
  • Coping Skills
  • Distress, Emotional